|

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

RECRUITINGN/ASponsored by Ulsan University Hospital
Actively Recruiting
PhaseN/A
SponsorUlsan University Hospital
Started2025-07-09
Est. completion2026-03
Eligibility
Age19 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07405931

Summary

This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults aged 19 years or older
* Diagnosed with early or advanced gastric, lung, breast, or colon cancer
* Starting first-cycle chemotherapy with a new anticancer agent
* Able to use a smartphone without difficulty
* Willing to provide informed consent to participate in the study

Exclusion Criteria:

* Individuals who have difficulty communicating due to cognitive impairment, visual impairment, hearing impairment, or other reasons
* Individuals who cannot read, write, or understand Korean
* Other individuals deemed inappropriate for participation by the investigators

Conditions11

Advanced Breast CancerAdvanced Colon CancerAdvanced Gastric CancerAdvanced Lung CancerBreast CancerCancerEarly Breast CancerEarly Colon CancerEarly Gastric CancerEarly Lung Cancer

Browse More Trials

Cancer trialsBreast Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.